Company Filing History:
Years Active: 2023
Title: Frank J Dellafera: Innovator in Sickle Cell Disease Treatment
Introduction
Frank J Dellafera is a notable inventor based in Locust Valley, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of vaso-occlusive crises associated with sickle cell disease. His innovative approach has the potential to improve the quality of life for many patients suffering from this condition.
Latest Patents
Dellafera holds a patent for a method of treating vaso-occlusive crises associated with sickle cell disease. The patent, titled "Method for treating vaso occlusive crises associated with sickle cell disease," involves administering a therapeutically effective amount of 4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate. This invention represents a significant advancement in the management of sickle cell disease.
Career Highlights
Throughout his career, Frank J Dellafera has worked with various companies, including Nicox S.a. and Fera Pharmaceuticals, LLC. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Dellafera has collaborated with notable professionals in the field, including Brigitte Duquesroix-Chakroun and Scott Florentino. These partnerships have likely enhanced his research and development efforts.
Conclusion
Frank J Dellafera's contributions to the treatment of sickle cell disease through his innovative patent highlight his dedication to improving patient care. His work exemplifies the impact that inventors can have on the medical field.